IGC Pharma Inc - Company Profile
Powered by 
All the sales intelligence you need on IGC Pharma Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how IGC Pharma Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with IGC Pharma Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
IGC Pharma Inc (IGC), formerly India Globalization Capital Inc, is a clinical-stage pharmaceutical company focused on developing treatments for Alzheimer's disease. Its main activities include research and development of drug candidates targeting various aspects of Alzheimer's, particularly agitation associated with the disease. Its major products include investigational drugs such as IGC-AD1, TGR-63, IGC-1C, IGC-1A, IGC-M3, and LMP. The company’s products are designed for patients with Alzheimer's disease, aiming to address symptoms and modify disease progression. The company markets its in-house brands and formulations in compliance with applicable laws and regulations. IGC operates in the life sciences segment and also has an infrastructure business that involves construction contracts and rental of heavy construction equipment. IGC is headquartered in Potomac, Maryland, the US.
Headquarters
United States of America
Address
10224 Falls Road, Potomac, Maryland, 20854
Website
www.igcpharma.com
Telephone
1 301 5294996
No of Employees
70
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
IGC (AFM)
Revenue (2025)
$1.3M
-5.5%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
45.2%
(2025 vs 2024)
Market Cap*
$28.1M
Net Profit Margin (2025)
XYZ
42.0%
(2025 vs 2024)
* As of and is in US$
IGC Pharma Inc premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Phytocannabinoid-based Therapies | Rental of Heavy Construction Equipment |
| Natrinol | |
| Pipeline: | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | IGC Pharma Inc | Texas Instruments Inc | Otsuka Holdings Co Ltd | Asia Allied Infrastructure Holdings Ltd | Axsome Therapeutics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Japan | Hong Kong | United States of America |
| City | Potomac | Dallas | Minato | Hong Kong City | New York City |
| State/Province | Maryland | Texas | Tokyo | - | New York |
| No. of Employees | 70 | 34,000 | 35,338 | 7,898 | 683 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Richard Prins | Chairman | Executive Board | 2012 | 68 |
| Ram Mukunda | Chief Executive Officer; Director; President | Executive Board | 2005 | 66 |
| Claudia Grimaldi | Chief Compliance Officer; Director; Principal Financial Officer; Vice President | Executive Board | 2018 | 54 |
| James Moran | Director | Non Executive Board | 2022 | 80 |
| Terry L. Lierman | Director | Non Executive Board | 2024 | 77 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer